| Keyword | CPC | PCC | Volume | Score | Length of keyword |
|---|---|---|---|---|---|
| bendamustine rituximab nssg | 0.49 | 0.2 | 4905 | 50 | 27 |
| bendamustine | 0.76 | 0.3 | 6544 | 42 | 12 |
| rituximab | 1.5 | 0.1 | 8547 | 45 | 9 |
| nssg | 1.14 | 0.1 | 8115 | 45 | 4 |
| Keyword | CPC | PCC | Volume | Score |
|---|---|---|---|---|
| bendamustine rituximab nssg | 0.56 | 0.9 | 4001 | 81 |
| nssg bendamustine and rituximab | 1.33 | 0.3 | 7699 | 25 |
| rituximab and bendamustine protocol | 0.03 | 0.2 | 3539 | 79 |
| rituximab and bendamustine regimen | 1.46 | 0.5 | 4490 | 99 |
| rituximab and bendamustine treatment | 1.04 | 0.5 | 9688 | 38 |
| bendamustine and rituximab for lymphoma | 1.76 | 0.3 | 5409 | 18 |
| bendamustine and rituximab for cll | 0.56 | 0.9 | 5245 | 63 |
| side effects of rituximab and bendamustine | 0.24 | 0.7 | 2714 | 69 |
| bendamustine and rituximab macmillan | 0.19 | 0.8 | 4763 | 38 |
| bendamustine rituximab waldenstrom protocol | 0.03 | 0.1 | 9124 | 50 |
| fiche patient rituximab bendamustine | 0.48 | 0.5 | 8110 | 29 |
